TY - JOUR AU - Rico-Fontalvo, Jorge AU - Daza-Arnedo, Rodrigo AU - Montejo-Hernández, Juan Diego AU - Romero-Martínez, Geraldine AU - Romero-Martínez, Shairine AU - Rodríguez-Yánez, Tomás PY - 2022/11/15 Y2 - 2024/03/28 TI - Use of dapagliflozin in patients with IgA Nephropathy: Report of a series of five cases JF - Revista Colombiana de Endocrinología, Diabetes & Metabolismo JA - Rev.ACE VL - 9 IS - 4 SE - Clinical cases DO - 10.53853/encr.9.4.774 UR - https://revistaendocrino.org/index.php/rcedm/article/view/774 SP - AB - <p><strong>Background</strong>: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are innovative therapies that have shown benefits beyond glycemic control. Experience and recently published clinical studies have confirmed its usefulness for the prevention of adverse renal and cardiovascular outcomes, therefore its benefits should be extrapolated to different populations outside of type 2 diabetes mellitus.</p><p><strong>Purpose</strong>: to present and describe the use of dapagliflozin in five patients with IgA Nephropathy.</p><p><strong>Case presentation</strong>: 5 cases of patients with non-diabetic chronic kidney disease are described, with multiple cardiovascular comorbidities, diagnosis confirmed by biopsy of IgA nephropathy, receiving usual therapy with RAS blockade, steroids according to the case criteria and management of comorbidities. In whom, due to persistence of albuminuria, dapagliflozin was added, with which a variable reduction in albuminuria values ??was obtained over time.</p><p><strong>Discussion and conclusion</strong>: the use of dapagliflozin was associated with a reduction in albuminuria levels in patients with IgA nephropathy, similar to that reported in studies such as DAPA-CKD. No comments can be made in relation to renal evolution and mortality due to the short follow-up time, for this reason, it is necessary in our environment to strengthen the regulations and addition to the management guidelines of these therapies in scenarios other than diabetes mellitus.</p> ER -